International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2023   Volume 13   Issue 3

Breast Cancer Associated Conventional and Advanced Therapies
Download PDF


, , , ,
Citation
Vancouver
Gautam KA, Singh N, Tyagi P, Jha G, Raman A. Breast Cancer Associated Conventional and Advanced Therapies. Int J Pharm Phytopharmacol Res. 2023;13(3):22-37. https://doi.org/10.51847/nQUUw5hfzg
APA
Gautam, K. A., Singh, N., Tyagi, P., Jha, G., & Raman, A. (2023). Breast Cancer Associated Conventional and Advanced Therapies. International Journal of Pharmaceutical And Phytopharmacological Research, 13(3), 22-37. https://doi.org/10.51847/nQUUw5hfzg
Download citation:   EndNote   RIS
Article Link:
Downloads: 209
Views: 822
Abstract

Globally, breast cancer (BC) is the second most lethal cancer that affects women and in rare cases, men as well. More than 90% of breast cancer-associated deaths are caused due to late identification that leads to metastasis. Biopsy report along with imaging work-up (MRI- and CT-scans) predicts the diagnosis that ultimately uses for the establishment of treatment options. Currently, breast cancer treatment has broad and diverse approaches, it comprises conventional treatments which include oncoplastic breast surgery, radiation therapy, and adjuvant chemotherapy while advanced treatments include systemic therapy approaches including targeted therapy, hormone therapy, and immunotherapy. Advanced treatments aim to attack cancer cells specifically, reduce side effects and improve treatment outcomes for patients. The therapies can be further diverged and depend on taking the grounds of molecular subtypes of BC, patient health, and personal preferences along with regular screening. In this review, we have highlighted different therapeutic approaches including targeted therapy, chemotherapy, and hormonal therapy employed based on molecular subtypes of BC.

Volume 15
Issue 1
2025

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2024 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.